We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0J2O market cap is 2.41B. The company's latest EPS is USD 2.1317 and P/E is 23.52.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 195.99M | 267.59M | 443.31M | 660.12M | 829.25M |
Operating Income | -67.61M | 144.26M | 275.9M | 267.53M | 337.57M |
Net Income | -72.24M | 129.09M | 402.71M | 202.13M | 281.59M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 565.87M | 579.92M | 1.1B | 1.84B | 1.73B |
Total Liabilities | 474.11M | 428.88M | 907.48M | 1.67B | 1.65B |
Total Equity | 91.77M | 151.05M | 196.95M | 169.8M | 83.81M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -85.42M | 55.45M | 299.44M | 240.11M | 388.57M |
Investing | -5.55M | 78.35M | -406.29M | -487.01M | -96.91M |
Financing | 153.22M | -106.28M | 77.87M | 362.37M | -407.99M |
Market Cap | 2.41B |
Price to Earnings Ratio | 23.52 |
Price to Sales Ratio | 7.99 |
Price to Cash Ratio | 55.95 |
Price to Book Ratio | 79.03 |
Dividend Yield | - |
Shares Outstanding | 132.1M |
Average Volume (1 week) | 2.7k |
Average Volume (1 Month) | 1.21k |
52 Week Change | 0.00% |
52 Week High | 18.26 |
52 Week Low | 18.26 |
Spread (Intraday) | 0 (0%) |
Company Name | Halozyme Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.halozyme.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions